Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
<p>Abstract</p> <p>Background</p> <p>The global gene regulator Special AT-rich sequence-binding protein1 (SATB1) has been reported to reprogramme tumour cells into a more malignant phenotype and associate with poor clinical outcome in several cancer forms. In this study...
Main Authors: | Nodin Björn, Hedner Charlotta, Uhlén Mathias, Jirström Karin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-09-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | http://www.ovarianresearch.com/content/5/1/24 |
Similar Items
-
Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
by: Nodin Björn, et al.
Published: (2012-01-01) -
Functional characterization of m Satb1 and Satb2 in the developing neocortex
by: De Juan Romero, Meury del Camino
Published: (2012) -
Poor prognosis and SATB1 overexpression in solid tumors: a meta-analysis
by: Wang S, et al.
Published: (2018-06-01) -
The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm
by: Najla Aldaoud, et al.
Published: (2019-11-01) -
Role of Satb1 and Satb2 Transcription Factors in the Glutamate Receptors Expression and Ca<sup>2+</sup> Signaling in the Cortical Neurons In Vitro
by: Egor A. Turovsky, et al.
Published: (2021-05-01)